Abstract
A 40-year-old woman was re-admitted due to haemoptysis 6 days after her patent foramen ovale (PFO) was successfully closed with the Amplatzer® PFO Occluder. Initially, a combination of aspirin (75 mg per day) and clopidogrel (75 mg per day) was given to protect against thrombus formation on the device. She complained of a cough but without dyspnoea. She presented normotensive and …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.